The editorial board is a group of opinion journalists whose views are informed by expertise, research, debate and certain longstanding values. It is separate from the newsroom. Thirteen years ago, no ...

My friend recently attended a funeral, and midway through the eulogy, he became convinced that it had been written by AI. There was the telltale proliferation of abstract nouns, a surfeit of ...

Wave Life Sciences has the fate of its lead RNA editing candidate back in its own hands. Partner GSK has decided not to take over development of WVE-006, an experimental oligonucleotide for alpha-1 ...

When Kathryn Ruemmler, a top Washington lawyer with an elite pedigree, joined Goldman Sachs GS-3.25%decrease; red down pointing triangle in 2020, she disclosed to top executives a connection that didn ...

All spark plugs may look the same to the untrained eye. Unfortunately, nothing could be further from the truth. For starters, spark plugs come in many types that are mainly differentiated by the ...

Neil Humphrey receives funding from various bodies including The National Lottery Community Fund to conduct research on young people's wellbeing Qiqi Cheng does not work for, consult, own shares in or ...

Derek Bartel didn’t recognize himself. Looking back at photos from a recent trip, he was convinced his wife had pulled a prank. “Oh my god, is that me?” Bartel, 39, recalled thinking, certain she’d ...

The company is finally expanding its product line that works with its long-range, low-power IoT network. The company is finally expanding its product line that works with its long-range, low-power IoT ...

Naox Wave EEG earbuds can track brain activity for consumers. The FDA cleared Naox's Link EEG earbuds for medical use. The brain-tracking tech makes EEG monitoring more accessible. Brain signal ...

Schools are facing a growing problem of students using artificial intelligence to transform innocent images of classmates into sexually explicit deepfakes. The fallout from the spread of the ...

Wave Life Sciences Ltd. (NASDAQ: WVE) on Monday shared interim data from the lowest therapeutic cohort of the ongoing first-in-human INLIGHT trial evaluating WVE-007, an investigational INHBE ...